These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 1739122)
21. Two distinct ubiquitin immunoreactive senile plaques in Alzheimer's disease: relationship with the intellectual status in 29 cases. He Y; Delaère P; Duyckaerts C; Wasowicz M; Piette F; Hauw JJ Acta Neuropathol; 1993; 86(1):109-16. PubMed ID: 8396836 [TBL] [Abstract][Full Text] [Related]
22. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease. Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433 [TBL] [Abstract][Full Text] [Related]
23. Neuritic pathology and dementia in Alzheimer's disease. McKee AC; Kosik KS; Kowall NW Ann Neurol; 1991 Aug; 30(2):156-65. PubMed ID: 1910274 [TBL] [Abstract][Full Text] [Related]
24. Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease. Siedlak SL; Cras P; Kawai M; Richey P; Perry G J Histochem Cytochem; 1991 Jul; 39(7):899-904. PubMed ID: 1865106 [TBL] [Abstract][Full Text] [Related]
25. Plaques and tangles and the pathogenesis of Alzheimer's disease. Armstrong RA Folia Neuropathol; 2006; 44(1):1-11. PubMed ID: 16565925 [TBL] [Abstract][Full Text] [Related]
26. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
27. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations. Sudo S; Shiozawa M; Cairns NJ; Wada Y J Neurol Sci; 2005 Jul; 234(1-2):55-65. PubMed ID: 15946688 [TBL] [Abstract][Full Text] [Related]
28. Neurofibrillary tangles of Guamanian amyotrophic lateral sclerosis, parkinsonism-dementia and neurologically normal Guamanians contain a 4- to 4.5-kilodalton protein which is immunoreactive to anti-amyloid beta/A4-protein antibodies. Guiroy DC; Mellini M; Miyazaki M; Hilbich C; Safar J; Garruto RM; Yanagihara R; Beyreuther K; Gajdusek DC Acta Neuropathol; 1993; 86(3):265-74. PubMed ID: 8213085 [TBL] [Abstract][Full Text] [Related]
29. Thy-1 in hippocampus: normal anatomy and neuritic growth in Alzheimer's disease. Leifer D; Kowall NW J Neuropathol Exp Neurol; 1992 Mar; 51(2):133-41. PubMed ID: 1347079 [TBL] [Abstract][Full Text] [Related]
30. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Guntern R; Bouras C; Hof PR; Vallet PG Experientia; 1992 Jan; 48(1):8-10. PubMed ID: 1371102 [TBL] [Abstract][Full Text] [Related]
31. Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques. Joachim C; Games D; Morris J; Ward P; Frenkel D; Selkoe D Am J Pathol; 1991 Feb; 138(2):373-84. PubMed ID: 1704190 [TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946 [TBL] [Abstract][Full Text] [Related]
33. Comparison of new and traditional methods for detection of senile plaques in Alzheimer's disease. Raskin LS; Applegate MD; Price DL; Troncoso JC; Hedreen JC J Geriatr Psychiatry Neurol; 1995 Apr; 8(2):125-31. PubMed ID: 7794478 [TBL] [Abstract][Full Text] [Related]
34. Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress. Praprotnik D; Smith MA; Richey PL; Vinters HV; Perry G Acta Neuropathol; 1996; 91(1):1-5. PubMed ID: 8773139 [TBL] [Abstract][Full Text] [Related]
36. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease. Ferrer I; Freixas M; Blanco R; Carmona M; Puig B Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978 [TBL] [Abstract][Full Text] [Related]
37. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Mazur-Kolecka B; Imaki H; Wegiel J; Mehta PD; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Pirttilla T; Frey H; Lehtimäki T; Kivimäki T; Visser FE; Kamphorst W; Potempska A; Bolton D; Currie JR; Miller DL Acta Neuropathol; 2007 Apr; 113(4):389-402. PubMed ID: 17237937 [TBL] [Abstract][Full Text] [Related]
38. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease. Thal DR; Härtig W; Schober R J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341 [TBL] [Abstract][Full Text] [Related]
39. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease. Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767 [TBL] [Abstract][Full Text] [Related]
40. Tangle-associated neuritic clusters. A new lesion in Alzheimer's disease and aging suggests that aggregates of dystrophic neurites are not necessarily associated with beta/A4. Munoz DG; Wang D Am J Pathol; 1992 May; 140(5):1167-78. PubMed ID: 1580329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]